BEGIN:VCALENDAR
PRODID:-//github.com/ical-org/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Lynn Madden\, PhD\, MPA (President\, CEO\, APT Foundation\, In
 c./Assistant Professor\, Yale School of Medicine) Dr. Madden is an Assist
 ant Professor at Yale School of Medicine and CEO of one of Connecticut's 
 largest addiction treatment programs providing comprehensive integrated s
 ervices for over 7000 patients. Her professional interests are focused on
  identifying treatment gaps to guide implementation. She has focused her 
 activities on improving both access to and retention in clinical care (ad
 diction treatment\, primary care\, HIV services) as well as understanding
  the relationships between improved access and treatment outcomes and cos
 t per episode of treatment. She is an MPI on two NIDA-funded grants focus
 ed on improving opioid use disorder identification and treatment that sim
 ultaneously focus on HIV (and HCV) identification and treatment as well a
 s coinvestigator on a NIDA-funded grant involving a stepped care design t
 o identify the sequence of several implementation strategies to achieve o
 ptimal pain medication prescribing by primary care physicians and a co-in
 vestigator on other current studies.Dr. Madden is an established and well
 -recognized consultant and facilitator working throughout the United Stat
 es since 2004\, Ukraine since 2014\, Central Asia since 2021\, and Peru s
 ince 2022 specializing in systems change\, improving treatment access\, s
 tigma reduction and program uptake and outcomes using rapid cycle process
  improvement\, decision science\, guideline development and implementatio
 n frameworks. She brings her expertise in using and evaluating implementa
 tion frameworks for improving access and creating financially and clinica
 lly sound programs to these research projects. QRDG Overview: The goal of
  the Qualitative Research Discussion Group (QRDG) is to provide opportuni
 ties for individuals involved in qualitative or mixed-methods research to
  meet regularly to discuss the qualitative research process and potential
 ly problem-solve issues that may arise when engaged in qualitative resear
 ch. Discussion topics include\, but are not limited to: logistics\, data 
 management\, analysis\, dissemination\, role of the researcher\, and ethi
 cs. It is intended as a venue for discussing research in progress and new
  or relevant literature on qualitative methods and practice as well as to
  create networking opportunities and foster research collaborations. CIRA
 's Dissemination Implementation Science and Methods (DISM) Core member\, 
 Lauretta Grau\, PhD\, is coordinating the meetings. She can be reached at
  lauretta.grau@yale.edu .\n\nSpeaker:\nLynn Madden\n\nAdmission:\nFree\n\
 nDetails URL:\nhttps://medicine.yale.edu/event/cira-qrdg-lynn-madden/\n
DTEND;TZID=America/New_York:20240920T130000
DTSTAMP:20261009T083551Z
DTSTART;TZID=America/New_York:20240920T120000
LOCATION:URL: https://yale.zoom.us/j/93012332332?pwd=dUo3Wi9rd3Z0ejF4WTczd
 W5tWHRpdz09dW5tWHRpdz09
SEQUENCE:0
STATUS:Confirmed
SUMMARY:CIRA Qualitative Research Discussion Group (QRDG): "Using Nominal 
 Group Technique to Elicit Barriers and Facilitators? As a research strate
 gy?”
UID:1a054927-5761-48ba-8faa-405d19e634e6
END:VEVENT
END:VCALENDAR